The key factors contributing to the growth of the global biomarker market include high prevalence of chronic diseases, rising adoption of biomarker for diagnostic applications, high government funding for cancer research and clinical trials, increasing application in drug discovery and development. High investments cost and low-cost benefit ratio and technical issue such sample collection and storage are restraining the growth of the biomarker market. however, introduction of new technologies such as digital biomarker and rising adoption in personalized medicine are creating opportunities for the market.